Genetic Technologies
GENE
#10484
Rank
โ‚น0.33 B
Marketcap
โ‚น68.73
Share price
0.00%
Change (1 day)
-66.73%
Change (1 year)

Genetic Technologies (GENE) - Total debt

Total debt on the balance sheet as of June 2024 : โ‚น52.62 Million

According to Genetic Technologies's latest financial reports the company's total debt is โ‚น52.62 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Genetic Technologies - Total debt on balance sheet (from 2004 to 2024)

Total debt by year

Year Total debt Change
2024-06-30โ‚น48.83 M68.71%
2023-06-30โ‚น28.94 M-18.35%
2022-06-30โ‚น35.45 M210.94%
2021-06-30โ‚น11.4 M-54.54%
2020-06-30โ‚น25.07 M
2019-06-30N/A
2015-06-30โ‚น1.21 M-99.14%
2014-06-30โ‚น0.14 B
2013-06-30N/A-100%
2012-06-30โ‚น1 M-68.82%
2011-06-30โ‚น3.23 M-78.34%
2010-06-30โ‚น14.94 M3.71%
2009-06-30โ‚น14.4 M17.49%
2008-06-30โ‚น12.26 M-31.8%
2007-06-30โ‚น17.97 M-68.96%
2006-06-30โ‚น57.91 M-14.53%
2005-06-30โ‚น67.76 M207.87%
2004-06-30โ‚น22.01 M2.04%
2003-06-30โ‚น21.57 M
2002-06-30N/A-100%
2001-06-30โ‚น2.88 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Eterna Therapeutics
ERNA
โ‚น49.59 M-5.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
โ‚น19.07 B 36,143.27%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚น586.63 B 1,114,666.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚น573.34 B 1,089,417.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
โ‚น0.26 B 402.93%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Danaher
DHR
โ‚น1.514 T 2,877,509.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚น3.205 T 6,091,090.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
โ‚น71.19 B 135,198.52%๐Ÿ‡บ๐Ÿ‡ธ USA